Since 1967, Fermilab has worked to answer these and other fundamental questions and enhance our understanding of everything we see around us. As the United States' premier particle physics laboratory, we work on the world's most advanced particle accelerators and dig down to the smallest building blocks of matter.
So, survival rate and life expectancy for stage 4 prostate cancer cannot be favorable. âº The five-year relative survival rate for prostate cancer that has spread to distant organs is 28%. This means about 28% of the patients with stage 4 prostate cancer will live for five years.
Women who are diagnosed with early stage ovarian cancer (stages I to II) have five-year survival rates that range from 57% to 90%. In contrast, the five-year survival rates for patients who are diagnosed with advanced stage disease range from 18% to 45%. Despite advances in surgery and platinum-based chemotherapy the mortality rates of individuals with ovarian cancer remain poor. In the past 40 years, the median five-year survival rate for women with advanced stage cancer has increased from 37% to 46%.